Ken Griffin Becton Dickinson & CO Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$221.47 - $242.41 $2.17 Million - $2.38 Million	-9,800 Reduced 4.99%	186,600 $45 Million
Q2 2024 Aug 14, 2024	SELL	$225.07 - $246.17 $10.6 Million - $11.6 Million	-47,300 Reduced 19.41%	196,400 $45.9 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $8.47 Million - $8.99 Million	-36,300 Reduced 12.96%	243,700 $60.3 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $11.7 Million - $13.4 Million	-50,200 Reduced 15.2%	280,000 $68.3 Million
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $43.9 Million - $48.9 Million	172,400 Added 109.25%	330,200 $85.4 Million
Q2 2023 Aug 14, 2023	BUY	$238.39 - $265.32 $4.12 Million - $4.59 Million	17,300 Added 12.31%	157,800 $41.7 Million
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $51.9 Million - $58.6 Million	-226,000 Reduced 61.66%	140,500 $34.8 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $10.3 Million - $12.1 Million	47,000 Added 14.71%	366,500 $93.2 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $8.65 Million - $44.8 Million	169,600 Added 113.14%	319,500 $71.2 Million

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.4B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.